Viewing nowJayrostatin 10 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

MFDS item code 201702528 · Approved 2017.05.23 · Insurance code 645405210
Treatment of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression
This medicine is used as an adjunctive therapy when diet and exercise are insufficient to control primary hypercholesterolemia and mixed dyslipidemia. It is also used as an adjunct to treat patients with homozygous familial hypercholesterolemia or dysbetalipoproteinemia. It lowers total cholesterol and LDL cholesterol levels, thereby delaying the progression of atherosclerosis and is also used in children aged 10 to under 17 who meet specific criteria for heterozygous familial hypercholesterolemia. Additionally, it is effective in reducing the risk of stroke, myocardial infarction, and arterial revascularization in adults with elevated high-sensitivity C-reactive protein levels and other cardiovascular risk factors. This medicine is used to improve cardiovascular health by controlling cholesterol levels.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams per day. 3. Elderly patients: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of a 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of a 40-milligram dose of this medicine is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (aged 10 to 17 years) The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Safety and efficacy in children under 10 years of age have not been established.
This medicine should not be used in certain patients. For example, those with an allergy to this drug, those with severe liver dysfunction, those with muscle diseases, and women who are pregnant or breastfeeding should not take this medicine. Additionally, its use may be limited in patients with severely impaired kidney function or those taking certain concomitant medications. Regular monitoring of liver function tests and muscle-related tests is required while taking this medicine, and patients should immediately inform their doctor if they experience symptoms such as muscle pain or weakness. Patients taking high doses need monitoring for kidney function. This medicine can interact with other drugs, so it is essential to inform your doctor or pharmacist about any other medications you are taking. Women of childbearing potential should use appropriate contraceptive methods, and this medicine should not be taken during pregnancy. In case of overdose, there is no specific antidote, so treatment should be symptomatic, along with monitoring liver function and muscle enzyme levels. This medicine can rarely cause serious skin reactions, liver damage, or muscle damage in some patients, so treatment should be stopped immediately and medical consultation sought if these symptoms occur. Caution is required when driving or operating machinery due to the potential for dizziness.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular muscle weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, sensory disturbances, chest discomfort, loss of appetite, abdominal bloating, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.
Pink round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Daiwoo Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Myungjin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Teragen Itex Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.